medline.ch Onkologie Urologische Tumoren

	Perioperative and oncological outcomes of thulium laser-ERBT versus conventional TURBT in non-muscle invasive bladder cancer: a meta-analysis of 2,934 patients. Lasers Med Sci Chen D, Zhou Z, Wei G, Zhang F. PMID: 41910817 [PubMed - in process]
	Uncommon but aggressive: A case series on urinary bladder neuroendocrine carcinomas. J Cancer Res Ther Jha T, Ahuja A, Sharma M, Goel HK. PMID: 41910308 [PubMed - indexed for MEDLINE]
	Renal cell carcinoma with hemangioblastoma-like features: A rare entity and a dignostic challenge. J Cancer Res Ther Derqaoui S, Mesmoudi S, Znati K, Bernoussi Z. PMID: 41910306 [PubMed - indexed for MEDLINE]
	AR-V7 expression in primary non-metastatic prostate cancer and its role in disease progression following initial therapy: a systematic review and meta-analysis. Prostate Int Quintanilha M, Saugo Faria H, Leal de Oliveira H, Meira Martins L, Simoni Brum I. PMID: 41908243 [PubMed]
	Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions. Prostate Int Roldan-Testillano R, Rodriguez-Sanchez L, Covarrubias C, Durazo-Ruiz F, Arezki A, Anidjar M, Sanchez-Salas R. PMID: 41908235 [PubMed]
	External validation of the cancer of the prostate risk assessment score to predict treatment failure after high-intensity focused ultrasound. Prostate Int Brazão ÉS Jr, Santos VE, Mourão TC, Gomes DC, Nobre JQC, Brazão GP, de Oliveira RAR, da Silva C, da Costa WH, Guimarães GC, Zequi SC. PMID: 41908230 [PubMed]
	Familial Risks in 317Â 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics. Eur Urol Open Sci Hemminki K, Zitricky F, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki O. PMID: 41908211 [PubMed]
	Novel Strategies for Precision Diagnosis and Treatment of Prostate Cancer Based on Multifunctional Nanocarrier Systems. Int J Nanomedicine Tang Z, Shen S, Gu C, Li S, Ni J, Yang D, Mi Y. PMID: 41907374 [PubMed - indexed for MEDLINE]
	Diagnostic accuracy of (18)F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study. Front Med (Lausanne) Urso L, Feletti F, Lancia F, Canella F, Cittanti C, Badrane I, Adamantiadis S, Uccelli L, Iudicello A, Nieri A, Caracciolo M, Rambaldi I, Bisi R, Manco L, Bagni I, Guidoboni M, Calabrò L, Ippolito C, Giganti M, Bartolomei M. PMID: 41907293 [PubMed]
	Decision-Making Dilemmas Among Elderly Prostate Cancer Patients Receiving (177)Lu-PSMA Therapy: A Qualitative Study. Patient Prefer Adherence Chen Y, Liu C, Li R, He Y, Li L. PMID: 41907155 [PubMed]
	Sequential Intravesical Gemcitabine and Docetaxel for Non-Muscle Invasive Bladder Cancer: A Narrative Review Across Risk Groups. Res Rep Urol Hemmati Ghavshough M, Fu MZ, Islam R, Patel D, Ghodoussipour S, Packiam VT. PMID: 41907065 [PubMed]
	Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non-Muscle Invasive Bladder Cancer: Real-World Incidence and Concomitant Medication Effects. Int J Urol Usui A, Hara T, Oka S, Sakaguchi K, Urakami S. PMID: 41907008 [PubMed - indexed for MEDLINE]
	Bladder Urothelial Neoplasms Profile in Dr. Soetomo General Academic Hospital Surabaya: Retrospective Study during 2013-2023. Urologia Ilmiah K, Parengkuan IL, Rahaju AS, Mastutik G, Djatisoesanto W. PMID: 41905878 [PubMed - as supplied by publisher]
	Conventional vs. Hypofractionated radiotherapy for high-risk prostate cancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMRT compared to 3D-CRT. Radiother Oncol Martínez C, Tisseverasinghe S, Karim MU, Ka K, Nabid A, Kaldany E, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M, Niazi T. PMID: 41905637 [PubMed - as supplied by publisher]
	From complexity to clarity: GPT-4 for patient-centered prostate cancer pathology reports. Patient Educ Couns Fereydooni S, Homer R, Chartash D. PMID: 41905268 [PubMed - as supplied by publisher]
	Association between pioglitazone use and prostate cancer in patients with type 2 diabetes: A retrospective cohort study. Cancer Epidemiol Lai SW, Liao KF. PMID: 41905181 [PubMed - as supplied by publisher]
	Moderate Hypofractionated Helical Tomotherapy for Localized Prostate Cancer in Older Patients: A Single-Institution Study of Toxicity and Outcomes. Technol Cancer Res Treat Meng L, Di Y, Ma L, Qu B. PMID: 41904699 [PubMed - indexed for MEDLINE]
	The identification of clinicopathological features predictive of recurrence following lymphadenectomy in penile cancer: A systematic review. Urol Oncol Garaz R, Peri J, Mirvald C, Muneer A, Alnajjar HM, Rausch S, Thomas A, Surcel C, Crozier J, Niyazi M, Haddad H, Tsaur I. PMID: 41904097 [PubMed - as supplied by publisher]
	Beyond clear cell: Rare histologic and molecular variants of renal cell carcinoma. Urol Oncol Moradi A, Fann J, Zhang G, Pal SK, Sadimin E. PMID: 41904096 [PubMed - as supplied by publisher]
	Cytomorphologic and molecular characterization of metastatic renal cell carcinoma diagnosed by fine-needle biopsy: a single-institution study. J Am Soc Cytopathol Kleinjan ML, Antic T. PMID: 41904061 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 177139

Seite 1 von 8857

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung